| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| BANDROWCZAK STEVEN JOHN | CEO, Director | XEROX HOLDINGS CORPORATION, P.O. BOX 4505 401 MERITT 7, NORWALK | /s/ Eric Risi, as attorney-in-fact | 21 Jan 2026 | 0001407036 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | XRX | Restricted Stock Unit | Options Exercise | $0 | -60,751 | -5.5% | $0.000000 | 1,052,549 | 18 Jan 2026 | Direct | F1 |
| transaction | XRX | Common Stock | Options Exercise | +60,751 | +15% | 475,427 | 18 Jan 2026 | Direct | F1, F2 | ||
| transaction | XRX | Common Stock | Tax liability | $60,547 | -22,260 | -4.7% | $2.72 | 453,167 | 18 Jan 2026 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | On January 18, 2023, the reporting person was granted an award of 178,678 Restricted Stock Units, which vests in three installments of 33%, 33% and 34% on the first, second and third anniversaries of the grant date. |
| F2 | Restricted Stock Units convert into common stock on a one-for-one basis. |
| F3 | Of the 60,751 Restricted Stock Units that vested, 22,260 were withheld and disposed of for taxes. |